Alerts will be sent to your verified email
Verify Email
KILITCH
|
Kilitch Drugs(India)
|
Fredun Pharma
|
Prevest Denpro
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.81 % | 8.53 % | 19.0 % |
|
5yr average Equity Multiplier
|
1.42 | 3.02 | 1.07 |
|
5yr Average Asset Turnover Ratio
|
0.51 | 1.01 | 0.6 |
|
5yr Avg Net Profit Margin
|
6.07 % | 2.89 % | 29.64 % |
|
Price to Book
|
3.07 | 4.1 | 6.41 |
|
P/E
|
22.2 | 24.75 | 35.83 |
|
5yr Avg Cash Conversion Cycle
|
-7.56 Days | 137.13 Days | 42.6 Days |
|
Inventory Days
|
17.9 Days | 140.46 Days | 36.0 Days |
|
Days Receivable
|
138.92 Days | 52.11 Days | 44.41 Days |
|
Days Payable
|
199.26 Days | 131.93 Days | 39.32 Days |
|
5yr Average Interest Coverage Ratio
|
5.07 | 2.31 | 99.71 |
|
5yr Avg ROCE
|
8.16 % | 16.75 % | 25.39 % |
|
5yr Avg Operating Profit Margin
|
9.07 % | 8.32 % | 36.91 % |
|
5 yr average Debt to Equity
|
0.14 | 0.86 | 0.0 |
|
5yr CAGR Net Profit
|
77.02 % | 52.4 % | 2.94 % |
|
5yr Average Return on Assets
|
3.38 % | 3.05 % | 17.71 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.23 % | 48.93 % | 73.6 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.98 % | -2.11 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kilitch Drugs(India)
|
Fredun Pharma
|
Prevest Denpro
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|